CD9 and glioblastoma: Moreover, western blot results suggested that compared with blood cell lysates, the high expression of EV markers CD63, CD9, and TSG101 could be detected in the serum-EVs of both GBM patients and healthy controls, whereas GBM-serum-EVs presented with higher levels of these markers following the same experimental procedures.